Menu Close

Here’s Major Breakthrough in Alzheimer’s in 100 Years

Here's Major Breakthrough in Alzheimer's in 100 Years

[Legitscience] – Over the past 100 years, significant progress has been achieved in the diagnosis, comprehension, prevention, and treatment of Alzheimer’s disease. Some of them include a nasal spray that might aid in illness prevention and the realization that the diversity of our guts affects the danger of the disorder.


Currently, a variety of tests, including memory and cognition tests, are used by doctors to diagnose Alzheimer’s disease. Although thorough, this multifaceted approach might take weeks to plan and execute. As a result, this takes up both the doctors’ and patients’ important time.

Scientists from Imperial College London have developed an innovative and user-friendly technology. This technology identifies Alzheimer’s disease with just one brain scan, revolutionizing previously time-consuming procedures.

It is crucial to be able to diagnose people promptly, precisely and conveniently. This is because it enables them to get support and assistance as soon as possible. Additionally, it supports research into Alzheimer’s disease, accelerating the creation of more advanced treatments.

Alzheimer’s disease diagnosis with a single brain scan

The procedure can be performed on a typical MRI machine, which is accessible in most hospitals. The patient’s MRI image can be assessed and diagnosed with 98 percent accuracy using an AI algorithm. The AI has been trained on brain scans of over 400 patients at various phases of the evolution of Alzheimer’s disease. Also, it can differentiate between early and late-stage Alzheimer’s with 79 percent accuracy.


“At this time, no other straightforward and commonly used method can predict Alzheimer’s disease with this degree of accuracy, thus our discovery represents a significant advancement,” lead researcher Eric Aboagye said.

“Even though many patients who visit memory clinics with Alzheimer’s also have other neurological disorders, even in this group, the system was able to distinguish between patients who had Alzheimer’s and those who did not,” Aboagye added.

“For patients and their families, waiting for a diagnosis can be a terrible ordeal. It would be really beneficial if we could shorten the time patients must wait. Also, streamline the diagnosing process and lessen some of the uncertainty.”


“Our novel approach may also make it easier to locate people who are at an early stage. This is for clinical trials for new drug treatments.”

More on Health

With the aid of this technology, additional regions linked to the illness have also been discovered, such as the cerebellum, which controls and coordinates physical activity, and the ventral diencephalon [linked to the senses, sight and hearing].

Share your thought